No BS RX Tirzepatide Review: $249 a Month, Four Pharmacies Named (2026)

No BS RX charges $249 a month for standard compounded tirzepatide, month to month, with blocks at $649 for twelve weeks, $1,289 for twenty-four and $2,599 for fifty-two. A separate low-dose tirzepatide program runs $140 a month. All of it sits on one public page with no intake and no account.¹ Read live on 13 September 2026.

The commitment it puts in writing

Under "OUR PRICING COMMITMENTS" the page says: "No Fake Intro Rate — We do not believe in showing one price upfront and surprising you later. The price on the page is the ongoing program price." On this site we check that sort of claim against the arithmetic rather than take it, and here it holds. The $140 in the hero is a real month-to-month rate on a real product — the low-dose injectable — not a fifty-two-week total quietly divided down. Most of this field cannot survive that check; the Rx.com headline is a six-month prepay on a different drug, Edessa leads with a six-month rung, and RX Bella's headline is a different product altogether.

Four pharmacies, with addresses

The Terms name every pharmacy that may dispense: Red Rock Compounding Pharmacy (1240 East 100 South, Suite 220, St. George, UT 84790), Health Warehouse (7107 Industrial Rd., Florence, KY 41042), Precision Medicine (2657 Merrick Road, Bellmore, NY 11710) and Triad Rx (26258 Pollard Road, Daphne, AL 36526), each with a phone number, each described as independently licensed.² Every program row on the pricing page also prints "503A pharmacy fulfillment" and "No dose-based price changes". Nothing else we review discloses that much about who actually fills the vial — Science & Co comes closest by declaring that it is not a compounding facility at all, without naming the one that is.

The one number that does not add up

The same $409 twelve-week block sits under three different monthly rates. Against the $140-a-month low-dose injectable it saves $11 over twelve weeks — 2.6% — while against the $179-a-month low-dose oral it saves $128, or 24%. Two very different offers are presented in identical cards with identical styling. If you are on low-dose injectable, the block is very nearly not a discount at all, and the page does not say so.

What is missing

The Terms name four pharmacies and no operating company: there is no LLC and no Inc anywhere in them. A company willing to publish four dispensing addresses and then not its own name is an odd combination, and it is the one disclosure gap in an otherwise unusually open program. The low-dose programs also stop at twelve weeks — only the standard programs carry twenty-four- and fifty-two-week rungs.

The sleep program beside it

No BS RX also prices a sleep line on the same page: an at-home study on an FDA-cleared ring at a cash price of $33 a month billed as $396 annually, sleep therapy from $129 per sixty-minute consult in a six-consult block or $149 for a single one, and medication support from $33 a month plus a $49 provider consult. Obstructive sleep apnea and obesity travel together, and tirzepatide is now approved for it in the brand product — see our guide to Zepbound for sleep apnea.

The brand-vs-compounded question

This is compounded tirzepatide, not Zepbound or Mounjaro. Compounding happens at a pharmacy, produces no FDA-approved finished product, and puts the vial outside what the pivotal trials measured. Our guide to whether compounded tirzepatide is still legal in 2026 covers where that stands.

Does the drug work? (Separate from the provider)

Pricing is the seller's problem; efficacy is the molecule's. SURMOUNT-1 put weight loss at roughly 15% to 21% of body weight over 72 weeks³, and SURMOUNT-5 placed it ahead of semaglutide head to head⁴, both on the approved brand product. Our tirzepatide evidence guide has the full picture.

The honest verdict

This is the most completely published price surface on the list — six programs, four terms, one page, no intake — with four dispensing pharmacies named and addressed, and a stated commitment not to bait with an intro rate that the numbers actually support. The two things to watch are the $409 block, which is a real discount on some rows and almost none on others, and the absence of an operating entity in the Terms. If you want a named prescribing physician and a named pharmacy in one place, Renlo Health has both. The ranked best tirzepatide providers list sets them against the field.